Decellularized extracellular matrix (dECM) is a natural material purified by removing cells, antigens and other components from animal or human tissues using different decellularisation techniques such as physical, chemical and biological.And it has the main components of extracellular matrix(ECM). Extracellular matrix (ECM) is the microenvironment for cell survival, and together with cells, it forms human tissues and organs, and its complex three-dimensional network structure consisting of numerous proteins and polysaccharides provides stable signal transmission and structural support for tissues and organs. Because of its ability to play a better repair and regeneration efficacy, decellularized extracellular matrix is considered to be a new generation of biomaterials suitable for regenerative medicine, which plays an increasingly important role in the fields of tissue repair, organ transplantation and regenerative medicine, and has great potential for development.

The technology platform, relying on a number of core patented technologies, has key technical capabilities in the preparation of decellularized extracellular matrix materials for different tissues and organs, the development of sheet biomedical materials and gel biomedical materials, the evaluation of biocompatibility of materials, the evaluation of functional restorative effects, the research and development of biological regenerative materials with various advantages, such as low immunogenicity, absorption and metabolism.And the platform also reserves various research and development technologies of new generation mainstream medical materials such as hyaluronic acid, PLA, PLLA, pectin, PCL, peptides, polyethylene, PVA, polyurethane, polytetrafluoroethylene, microcrystalline calcium, chitosan, hydroxyapatite, humanized collagen, etc. Its products are widely used in the fields of tissue repair, surgical patches, medical aesthetic fillers and cell therapy and so on, in various forms to meet different clinical needs.